Juno Therapeutics (Germany)

Juno Therapeutics (Germany)

Juno Therapeutics Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Juno Therapeutics (Germany), Germany, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

73%


Total
Publications

51


Total Open
Publications

37


Total
Citations

2.1K


Open Access
Percentage

73%


Total
Publications

51


Total Open
Publications

37


Total
Citations

2.1K

Wikipedia

Website

download

Breakdown

25% 24% 24% 27%

Publisher Open

25%

Both

24%

Other Platform Open

24%

Closed

27%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

10

Hybrid 32%

8

No Guarantees 28%

7

Other Platform Open

Domain 71%

17

Institution 33%

8

Preprint 17%

4

Public 4%

1

Other Internet 4%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
17
Europe PMC
Domain
12
bioRxiv
Preprint
3
University of Toronto - TSpace
Institution
1
University of California - eScholarship University of California
Institution
1
Universidad Autónoma de Madrid - Biblos-e Archivo
Institution
1
tum.de OAI-PMH Repository
Institution
1
Technische Universität München - mediaTUM Gesamtbestand
Institution
1
Research Square
Preprint
1
Max Planck Society - MPG.PuRe
Institution
1
1 / 2

Data updated 7 April 2025

Share

Share

Share